The Role of TPA I/D and PAI-1 4G/5G Polymorphisms in Multiple Sclerosis

<table>Meta-analysis of the four case-control studies of MS and the PAI-1 4G/5G polymorphism. Comparisons were made between the 5G5G and 4G4G+4G5G genotypes. Summary ORs and respective 95% CIs were calculated using the fixed-effect model.</table>

Disease Markers

fig2

Figure 2

Figure 2: The Role of TPA I/D and PAI-1 4G/5G Polymorphisms in Multiple Sclerosis 